Alliancebernstein L.P. Sells 34,958 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Alliancebernstein L.P. lessened its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 2.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,184,881 shares of the real estate investment trust’s stock after selling 34,958 shares during the period. Alliancebernstein L.P. owned 0.17% of Healthpeak Properties worth $24,018,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. JPMorgan Chase & Co. grew its position in Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after purchasing an additional 4,056,931 shares during the last quarter. M&T Bank Corp purchased a new stake in shares of Healthpeak Properties during the 3rd quarter valued at about $22,995,000. HighTower Advisors LLC purchased a new stake in shares of Healthpeak Properties in the 3rd quarter worth $4,141,000. Diamant Asset Management Inc. bought a new position in shares of Healthpeak Properties in the third quarter worth about $564,000. Finally, Public Employees Retirement System of Ohio bought a new stake in Healthpeak Properties during the 3rd quarter worth approximately $29,226,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Trading Down 1.3 %

Shares of NYSE:DOC opened at $18.20 on Tuesday. Healthpeak Properties, Inc. has a 12-month low of $17.56 and a 12-month high of $23.26. The business’s fifty day simple moving average is $20.05 and its 200-day simple moving average is $20.98. The company has a market capitalization of $12.73 billion, a PE ratio of 51.99, a P/E/G ratio of 2.17 and a beta of 1.02. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96.

Healthpeak Properties Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Stockholders of record on Friday, February 14th were issued a $0.305 dividend. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 dividend on an annualized basis and a dividend yield of 6.70%. The ex-dividend date of this dividend was Friday, February 14th. Healthpeak Properties’s dividend payout ratio (DPR) is currently 348.57%.

Analysts Set New Price Targets

A number of research firms have commented on DOC. Scotiabank decreased their price target on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a report on Friday, February 28th. Robert W. Baird decreased their price target on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Tuesday, February 11th. Wedbush lowered their price objective on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, February 14th. Morgan Stanley upgraded shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 target price for the company in a report on Wednesday, January 15th. Finally, StockNews.com upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Saturday, March 22nd. Four analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $23.83.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.